Prescribed medications for patients with amphetamine-type stimulant use disorder seen in rural-serving Pacific Northwest primary care clinics
Abstract Background Amphetamine-type stimulant use and overdoses have increased sharply across the US in recent years, largely driven by methamphetamine. Increased access to treatments for amphetamine-type stimulant use disorder (AT-StUD), including in primary care settings, is needed to mitigate th...
Saved in:
| Main Authors: | Megan J. Yerton, Connor J. McCabe, Matthew D. Iles-Shih, Judith I. Tsui, Kevin A. Hallgren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Addiction Science & Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13722-025-00593-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urine methamphetamine-to-amphetamine ratio by LC-MS/MS to differentiate methamphetamine use from pharmaceutical impurity in patients prescribed amphetamine
by: Lindsey Contella, et al.
Published: (2025-08-01) -
MDMA as well as amphetamine and alcohol increase feelings of social closeness in healthy adults
by: Harriet de Wit, et al.
Published: (2024-12-01) -
FATAL AMPHETAMINE AND METHAMPHETAMINE POISONING DUE TO BODY PACKER SYNDROME: AUTOPSY CASE
by: Talip Vural, et al.
Published: (2024-10-01) -
Concordance of Biochip-Based and LC-MS/MS Methods in Urine and Blood Samples in Screening for Amphetamine and Methamphetamine
by: Murat Akbaba, et al.
Published: (2025-01-01) -
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
by: Elenore P. Bhatraju, et al.
Published: (2025-01-01)